Response to Pembrolizumab in a Patient with Relapsing Thymoma.

Zander, Thilo; Aebi, Stefan; Rast, Anna Christina; Zander, Andrea; Winterhalder, Ralph; Brand, Christoph; Diebold, Joachim; Gautschi, Oliver

Zander, Thilo; Aebi, Stefan; Rast, Anna Christina; Zander, Andrea; Winterhalder, Ralph; Brand, Christoph; Diebold, Joachim; Gautschi, Oliver.

Afiliação

Zander T; Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland. Electronic address: thilo.zander@luks.ch.
Aebi S; Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Rast AC; Department of Dermatology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Zander A; Department of Radiology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Winterhalder R; Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Brand C; Department of Dermatology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Diebold J; Department of Pathology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Gautschi O; Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.

J Thorac Oncol ; 11(12): e147-e149, 2016 12.

Article em En | MEDLINE | ID: mdl-27498287

Assuntos

Anticorpos Monoclonais Humanizados/uso terapêutico; Antineoplásicos Imunológicos/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Timoma/tratamento farmacológico; Neoplasias do Timo/tratamento farmacológico; Humanos; Masculino; Pessoa de Meia-Idade; Recidiva Local de Neoplasia; Radioterapia Adjuvante; Timoma/patologia; Neoplasias do Timo/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google